/UMAX

UMAX Stock - UMAX Group Corp.

Q: What is the analyst price target for UMAX?

Analyst price target information is not currently available for UMAX.

Q: What is UMAX's market cap?

Market capitalization information is not currently available for UMAX.

Financial Services|Shell Companies|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for UMAX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta5.85

52W High$0.01

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2018
Revenue	$43,045	$56,071	$628,016	N/A	$3,970
Gross Profit	$-51,152	$-314,864	$101,558	$-2,601	$278
Gross Margin	-118.8%	-561.5%	16.2%	N/A	7.0%
Operating Income	$-352,934	$-834,180	$-185,520	$-102,910	$-90,942
Net Income	$-365,030	$17.40M	$-162,181	$89,116	$-318,876
Net Margin	-848.0%	31028.2%	-25.8%	N/A	-8032.1%
EPS	$-0.00	$0.03	$-0.00	$0.00	$-0.00

Company Overview

UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company's products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.

Visit Website

Frequently Asked Questions about UMAX

What is UMAX's current stock price?

UMAX Group Corp. (UMAX) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for UMAX?

No analyst price targets are currently available for this stock.

What sector is UMAX Group Corp. in?

UMAX Group Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.

What is UMAX's market cap?

UMAX Group Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does UMAX pay dividends?

No, UMAX Group Corp. does not currently pay a dividend to shareholders.